The content and clinical utility of psychiatric advance directives

Psychiatric Services

Volumn 56, Issue 5, 2005, Pages 592-598

  Srebnik, Debra S ^a,e   Rutherford, Lindsay T ^b   Peto, Tracy ^c   Russo, Joan ^a   Zick, Ellen ^a   Jaffe, Craig ^a   Holtzheimer, Paul ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BOSTON COLLEGE   (United States)

^d EMORY UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; COMPUTER PROGRAM; DECISION MAKING; ELECTROCONVULSIVE THERAPY; FEMALE; HOSPITALIZATION; HUMAN; LIVING WILL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; OUTPATIENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT PARTICIPATION; SCHIZOPHRENIA;

EID: 17844371092     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.56.5.592     Document Type: Article

References (22)

1. Hoge S: The Patient Self-Determination Act and psychiatric care. Bulletin of the American Academy of Psychiatry and the Law 22:577-586, 1994
2. Srebnik, D, LaFond J: Advance directives for mental health treatment. Psychiatric Services 50:919-925, 1999
3. Swanson J, Tepper M, Backlar P, et al: Psychiatric advance directives: An alternative to coercive treatment? Psychiatry 63:160-172, 2000
4. Winick B: Advance directive instruments for those with mental illness. University of Miami Law Review 51:57-95, 1996
5. Frese F: Advocacy, recovery, and the challenges of consumerism for schizophrenia. Psychiatric Clinics of North America 21:233-249, 1998
6. Srebnik D: Benefits of Psychiatric Advance Directives: Can We Realize Their Potential? Journal of Forensic Psychology Practice: in press
7. Backlar P, McFarland, B, Bentson H, et al: Consumer, provider, and informal caregiver opinions on psychiatric advance directives. Administration and Policy in Mental Health 28:427-441, 2001
8. Geller J: The use of advance directives by persons with serious mental illness for psychiatric treatment. Psychiatric Quarterly 71:1-13, 2000
9. LaFond J Srebnik D: The impact of mental health advance directives on patient perceptions of coercion in civil commitment and treatment decisions. International Journal of Law and Psychiatry 25:537-555, 2002
10. Sutherby K, Szmukler G: Crisis cards and self-help crisis initiatives. Psychiatric Bulletin 22:4-7, 1998
11. Swanson J, Swartz M, Hannon M, et al: Psychiatric advance directives: A survey of persons with schizophrenia, family members, and treatment providers. International Journal of Forensic Mental Health 2:73-86, 2003
12. Backlar P, McFarland B: A survey on use of advance directives for mental health treatment in Oregon. Psychiatric Services 47:1389-1389, 1996
13. Miller R: Advance directives for psychiatric treatment: A view from the trenches. Psychology, Public Policy, and Law 4:728-745, 1998
14. Rosenson M, Kasten A: Another view of autonomy: Arranging for consent in advance. Schizophrenia Bulletin 17:1-7, 1991
15. Fleischner R: Advance Directives for Mental Health Care: An analysis of State Statutes, Psychology, Public Policy, and Law 4:788-804, 1998
16. Srebnik D, Brodoff L: Implementation of mental health advance directives: Service provider issues and answers. Journal of Behavioral Health Services and Research 30:253-268, 2003
17. Sherman P: Computer-assisted creation of psychiatric advance directives. Community Mental Health Journal 34:351-362, 1998
18. Swanson J, Swartz M: Psychiatric advance directives: Considerations and questions for research. Presented at the MacArthur Initiative on Mandated Community Treatment, Concord, Massachusetts, Oct 2001
19. Endicott J, Spitzer R, Fleiss J, et al: The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33:766-771, 1976
20. Menzin J, Boulanger L, Friedman M, et al: Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatric Services 54:719-723, 2003
21. Mojtabai R, Lavelle J, Gibson PJ, et al: Atypical antipsychotics in first admission schizophrenia: Medication continuation and outcomes. Schizophrenia Bulletin 9:519-530, 2003
22. Backlar P, McFarland B: Oregon's advance directive for mental health treatment: Implications for policy. Administration and Policy in Mental Health 25:609-618, 1998